alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 88, Number 184 (Monday, September 25, 2023)]
[Notices]
[Page 65759]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20824]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Sunshine Act Meetings

    The National Science Board's (NSB) NSB-NSF Commission on Merit 
Review hereby gives notice of the scheduling of a videoconference 
meeting for the transaction of National Science Board business pursuant 
to the National Science Foundation Act and the Government in the 
Sunshine Act.

TIME AND DATE: Wednesday, September 27, 2023, from 12:00 p.m.-1:00 p.m. 
EDT.

PLACE: This meeting will be held by videoconference through the 
National Science Foundation.

STATUS: Open.

MATTERS TO BE CONSIDERED: The agenda of the meeting is: Commission 
Chair's opening remarks; Presentation and discussion of the potential 
for additional Merit Review criteria; Commission Chair's closing 
remarks.

CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting 
is: (Chris Blair, <a href="/cdn-cgi/l/email-protection#92f1f0fef3fbe0d2fce1f4bcf5fde4"><span class="__cf_email__" data-cfemail="afcccdc3cec6ddefc1dcc981c8c0d9">[email protected]</span></a>), 703/292-7000. Members of the public 
can observe this meeting through a YouTube livestream. The YouTube link 
will be available from the NSB web page.

Christopher Blair,
Executive Assistant to the National Science Board Office.
[FR Doc. 2023-20824 Filed 9-21-23; 11:15 am]
BILLING CODE 7555-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
March 24, 1965

No. 69185.

#### Seedman International Corp. *v.*United States, Liebermann Waelchli *&*Co., N.Y., Inc., et al. *v.*United States,

protests 63/13408 and 63/15351;

protests 63/17834, etc.

Plaintiffs’ application for rehearing granted.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 296 Engrossed in House (EH)]

                In the House of Representatives, U. S.,

                                                          May 15, 2007.
Whereas the term ``eosinophilic disorders'' is a general term used to describe a 
        group of diseases and disorders caused by the production of too many 
        white blood cells called eosinophils;
Whereas eosinophilic disorders patients suffer from their immune system 
        attacking their body's own normal, healthy tissue, resulting in 
        inflammation or swelling;
Whereas an estimated 50,000 people are affected by eosinophilic disorders in the 
        United States, many of whom remain undiagnosed or misdiagnosed;
Whereas inflammatory eosinophilic disorders are thought to be both allergic and 
        autoimmune diseases, such that the body's immune system, which normally 
        fights infections and viruses, mistakes common food proteins and 
        environmental allergens as foreign;
Whereas eosinophilic disorders cause chronic illness that significantly impacts 
        a person's quality of life and ability to attend school and work, and 
        dramatically alters dietary lifestyles;
Whereas some eosinophilic disorders cause life-threatening and sometimes fatal 
        illnesses by causing inflammation of the vital organs, such as the 
        heart, lungs, kidney, and gastrointestinal tract;
Whereas eosinophilic disorders are difficult to diagnose and treatment is often 
        delayed, resulting in unnecessary suffering;
Whereas many patients with eosinophilic disorders often have severe long-term 
        disabilities as well as the severe limitations imposed by the disease 
        itself;
Whereas some eosinophilic disorder patients will suffer permanent irreversible 
        organ damage as a result of delays in diagnosis and proper treatment; 
        and
Whereas the American Partnership For Eosinophilic Disorders has identified the 
        third week of May as an appropriate time to recognize National 
        Eosinophil Awareness Week in order to educate communities across the 
        Nation about eosinophilic disorders and the need for research funding, 
        accurate diagnosis, and effective treatments: Now, therefore, be it
    Resolved,  That the House of Representatives--
            (1) supports the goals and ideals of National Eosinophil Awareness 
        Week; and
            (2) encourages health care providers and the American Partnership 
        for Eosinophilic Disorders to increase education and awareness regarding 
        eosinophilic disorders.
            Attest:

                                                                          Clerk.
```
1

The Honorable Linda R. Reade, Chief Judge, United States District Court for

the Northern District of Iowa.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 09-2842

___________

United States of America, *

*

Appellee, * Appeal from the United States

* District Court for the

v. * Northern District of Iowa.

*

Robert Orlando Bolden, * [UNPUBLISHED]

*

Appellant. *

___________

Submitted: April 14, 2010

Filed: April 19, 2010

___________

Before LOKEN, BYE, and SHEPHERD, Circuit Judges.

___________

PER CURIAM.

Robert Bolden challenges the reasonableness of the sentence the district court1

imposed after revoking his supervised release. Upon careful review, we hold that the

district court did not clearly err in finding by a preponderance of the evidence that

Bolden had violated the conditions of his supervised release, see United States v.

Carothers, 337 F.3d 1017, 1019 (8th Cir. 2003) (government must prove by
-2-

preponderance of evidence that defendant violated supervised release condition;

district court’s finding that violation occurred is reviewed for clear error; district

court’s credibility determinations at supervised release revocation hearing are virtually

unreviewable on appeal), and we conclude that the revocation sentence is not

unreasonable, see United States v. Tyson, 413 F.3d 824, 825 (8th Cir. 2005) (per

curiam) (revocation sentences are reviewed for unreasonableness in accordance with

United States v. Booker, 543 U.S. 220 (2005)).

Accordingly, we affirm the district court’s judgment. We grant counsel’s

motion to withdraw, subject to counsel informing Bolden about procedures for

seeking rehearing or filing a petition for certiorari.

______________________________
Exhibit 4.13



 Exhibit 4.13 
 CONSENT OF EXPERT 
 January 7, 2013 

I, Christopher Moreton, Ph.D., P.Geo., hereby consents to (1) the references to my name included or incorporated by reference in the registration
statement on Form F-80 of Denison Mines Corp. in connection with the report entitled “Technical Report on the EZ1 and EZ2 Breccia Pipes, Arizona Strip District, USA” dated June 24, 2009 as updated for Energy Fuels Inc. entitled
“Technical Report on the EZ1 and EZ2 Breccia Pipes, Arizona Strip District, USA” dated June 27, 2012 and (2) all other references to the undersigned included or incorporated by reference in the registration statement on Form F-80 of
Denison Mines Corp. dated January 2013. 
  

					
			
	/s/ Christopher Moreton	 		 	 
	 Christopher Moreton, Ph.D., P.Geo.
EXHIBIT 13.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Global Ship Lease, Inc. (the Company) on Form 20-F/A for the year ended
December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Form 20-F/A), I Ian J. Webber, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Form 20-F/A fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Form 20-F/A fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------

Dated: September 16, 2010



|    |  |                              
|--- |  | -----------------------------
|By: |  | /s/ Ian J. Webber            
|    |  | Ian J. Webber                
|    |  | Chief Executive Officer      
|    |  | (Principal Executive Officer)
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001037478
<NAME>                        Fonda Group Inc
<MULTIPLIER>                  1000

<S>                             <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                          SEP-24-2000
<PERIOD-START>                             SEP-27-1999
<PERIOD-END>                               MAR-26-2000
<CASH>                                           1,332
<SECURITIES>                                         0
<RECEIVABLES>                                   48,186
<ALLOWANCES>                                     2,083
<INVENTORY>                                     66,813
<CURRENT-ASSETS>                               126,215
<PP&E>                                          72,146
<DEPRECIATION>                                  22,443
<TOTAL-ASSETS>                                 225,450
<CURRENT-LIABILITIES>                          212,514
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      12,936
<TOTAL-LIABILITY-AND-EQUITY>                   225,450
<SALES>                                        175,635
<TOTAL-REVENUES>                               175,635
<CGS>                                          142,814
<TOTAL-COSTS>                                  142,814
<OTHER-EXPENSES>                                24,068
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,153
<INCOME-PRETAX>                                    600
<INCOME-TAX>                                       234
<INCOME-CONTINUING>                                366
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                   (525)
<CHANGES>                                            0
<NET-INCOME>                                      (159)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0



</TABLE>
EXHIBIT 32.1



inTEST CORPORATION



In connection with the Quarterly Report of inTEST Corporation (the "Company") on Form 10-Q for the period ending June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert E. Matthiessen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:	August 14, 2009

/s/ Robert E. Matthiessen
Robert E. Matthiessen
President and Chief Executive Officer
EPA, 2009e. Email Communication

From: Hoffman.Wendy@epamail.epa.gov

Sent: Thursday, May 14, 2009 4:39 PM

To: Kristina Watts; Kimberly Wilson; john_bovay@abtassoc.com

Subject: Fw: Clarifying question on IUR data you sent me on Tues.

Hi -- This is what I got from Darry. Kristina was right, that there are a lot CAS #s

with no reports -- Wendy

----- Forwarded by Wendy Hoffman/DC/USEPA/US on 05/14/2009 04:37 PM

-----

 

 Re: Clarifying question on IUR data you sent me on Tues. (Document 

 link: Wendy Hoffman) 

 Darryl Ballard 

 to: 

 Wendy Hoffman 

 05/14/2009 03:32 PM 

88 CASRNs with reports, 652 with no reports (Total = 740 CASRNs)

 

 

 From: Wendy Hoffman/DC/USEPA/US 

 

 

 To: Darryl Ballard/DC/USEPA/US@EPA 

 

 

 Date: 05/14/2009 01:24 PM 

 

 

 Subject: Re: Clarifying question on IUR data you sent me on Tues. 

 

 

Can you give me the counts pretty quickly? I take it then that were CAS #s for which

you got no reports? 

Thanks.

 

 

 From: Darryl Ballard/DC/USEPA/US 

 

Page 1
EPA, 2009e. Email Communication

 

 To: Wendy Hoffman/DC/USEPA/US@EPA 

 

 

 

 Date: 05/14/2009 01:02 PM 

 

 

 Subject: Re: Clarifying question on IUR data you sent me on Tues. 

 

 

Both. Do you need counts on those?

Darryl

 

 

 From: Wendy Hoffman/DC/USEPA/US 

 

 

 To: Darryl Ballard/DC/USEPA/US@EPA 

 

 

 Date: 05/14/2009 09:30 AM 

 

 

 Subject: Clarifying question on IUR data you sent me on Tues. 

 

 

HI, Darryl -- I have a clarification to ask about the data you sent me (below). For

the question about the 

IUR Chems Subject to Orders, you gave me a list of 7 CAS #s and 1 accession # that 

reported PV of less 

than 25,000 lbs. Does that mean I can assume that all the others had reported 

submitted that had 

volumes of 25,000 lbs or greater, or were there any/many that had no reports at all?

Thanks very much -

- Wendy

 

 

 From: Darryl Ballard/DC/USEPA/US 

 

Page 2
EPA, 2009e. Email Communication

 

 

 To: Wendy Hoffman/DC/USEPA/US@EPA 

 

 

 Date: 05/12/2009 07:10 PM 

 

 

 Subject: Re: Fw: one more query on IUR database...... 

 

 

I believe the numbers you are looking for are in the attached document.

If you have any questions or need anything else, please let me know.

Darryl Ballard

Acting Branch Chief, RDMB

(202) 564-8958

[attachment "One More Query On IUR Database.doc" deleted by Darryl 

Ballard/DC/USEPA/US]

Page 3
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                              11
<SECURITIES>                                         0
<RECEIVABLES>                                        5
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                    16
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                      16
<CURRENT-LIABILITIES>                               69
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            16
<OTHER-SE>                                        (68)
<TOTAL-LIABILITY-AND-EQUITY>                        16
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                       51
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   (51)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (51)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (51)
<EPS-BASIC>                                        .00
<EPS-DILUTED>                                      .00


</TABLE>
[Federal Register Volume 88, Number 179 (Monday, September 18, 2023)]
[Notices]
[Pages 63980-63981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20069]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Committee on Equal Opportunities in Science and Engineering; 
Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation (NSF) announces the 
following meeting:
    Name and Committee Code: Committee on Equal Opportunities in 
Science and Engineering (CEOSE) (#1173) (Virtual).
    Date and Time: October 26, 2023; 10 a.m.-4:15 p.m.
    Place: National Science Foundation, 2415 Eisenhower Avenue, 
Alexandria, VA 22314 (Virtual)
    Meeting Registration: Virtual attendance information will be 
forthcoming on the CEOSE website at http://www.nsf.gov/od/oia/activities/ceose/index.jsp.
    Type of Meeting: Open.
    Contact Person: Dr. Bernice Anderson, Senior Advisor and CEOSE 
Executive Secretary, Office of Integrative Activities (OIA), National 
Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314.
    Contact Information: <a href="/cdn-cgi/l/email-protection#083f383b253a313a2530383c38276a69666c6d7a7b6748667b6e266f677e">703-292-8040/<span class="__cf_email__" data-cfemail="6c0e0d0208091e1f032c021f0a420b031a">[email protected]</span></a>.
    Minutes: Meeting minutes and other information may be obtained from 
the CEOSE Executive Secretary at the above address or the website at 
http://www.nsf.gov/od/oia/activities/ceose/index.jsp.
    Purpose of Meeting: To study data, programs, policies, and other 
information pertinent to the National Science Foundation and to provide 
advice and recommendations concerning broadening participation in 
science and engineering.

Agenda

October 26, 2023

10:00 a.m.-10:30 a.m. Welcome, Introductions, Opening Remarks
10:30 a.m.-11:00 a.m. Report of the NSF CEOSE Executive Liaison
11:00 a.m.-12:00 p.m. Presentation: NSF Initiatives to Advance Persons 
with Disabilities in STEM
12:00 p.m.-12:45 p.m. Lunch

[[Page 63981]]

12:45 p.m.-1:00 p.m. Update on Dissemination Activities of the 2021-
2022 CEOSE Report
1:00 p.m.-1:30 p.m. Discussion with NSF Leadership
1:30 p.m.-2:45 p.m. Discussion: CEOSE Rural STEM Education Report/Brief
2:45 p.m.-3:00 p.m. Break
3:00 p.m.-4:00 p.m. Reports of the CEOSE AC Liaisons and CEOSE Federal 
Liaisons
4:00 p.m.-4:15 p.m. Announcements and Final Remarks

    Dated: September 12, 2023.
Crystal Robinson,
Committee Management Officer.
[FR Doc. 2023-20069 Filed 9-15-23; 8:45 am]
BILLING CODE 7555-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
From: debbiekuzdal@att.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 3:16:28 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Debbie Kuzdal

Grandville, MI 49418
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     This schedule  contains summary  financial  information  extracted from the
consolidated  financial  statements of GFSI, Inc. for the quarter ended April 2,
1999 and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK>                         0001036327
<NAME>                        GFSI, Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars
       
<S>                             <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                              JUL-02-1999
<PERIOD-START>                                 JUL-03-1998
<PERIOD-END>                                   APR-02-1999
<EXCHANGE-RATE>                                1
<CASH>                                         10,021
<SECURITIES>                                   0
<RECEIVABLES>                                  29,357
<ALLOWANCES>                                   0
<INVENTORY>                                    33,835
<CURRENT-ASSETS>                               76,048
<PP&E>                                         47,034
<DEPRECIATION>                                 18,835
<TOTAL-ASSETS>                                 103,748
<CURRENT-LIABILITIES>                          28,199
<BONDS>                                        176,266
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     (102,209)
<TOTAL-LIABILITY-AND-EQUITY>                   103,748
<SALES>                                        160,229
<TOTAL-REVENUES>                               160,229
<CGS>                                          89,533
<TOTAL-COSTS>                                  44,300
<OTHER-EXPENSES>                               141
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             14,081
<INCOME-PRETAX>                                12,456
<INCOME-TAX>                                   5,037
<INCOME-CONTINUING>                            7,419
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   7,419
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
        

</TABLE>
No. 65119.

#### F. W. Myers & Co. *v.*United States,

protest 265828-K (Ogdensburg).

Opinion by

Donlon, J.

In accordance with stipulation of counsel that the merchandise and issues are similar in all material respects to those involved in *United States*v. *The Best Foods, Inc.*(47 C.C.P.A. 163, C.A.D. 751), the claim of the plaintiff was sustained.